Trial Profile
Qualitative Study on Experiences Related to Anorexia and the Effects of Anamorelin and Placebo in Advanced Non-Small-Cell Lung Cancer Patients With Anorexia-Cachexia: A Preliminary Study
Status:
Active, no longer recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 17 Mar 2023
Price :
$35
*
At a glance
- Drugs Anamorelin (Primary)
- Indications Anorexia; Cachexia
- Focus Therapeutic Use
- 13 Mar 2023 Planned End Date changed from 31 Dec 2022 to 31 Dec 2024.
- 13 Mar 2023 Planned primary completion date changed from 31 Dec 2022 to 31 Dec 2024.
- 13 Jan 2022 Status changed from recruiting to active, no longer recruiting.